{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchangeTimezoneShortName": "EDT", "exchangeTimezoneName": "America/New_York", "esgPopulated": false, "regularMarketChangePercent": -1.015493, "currency": "USD", "regularMarketPrice": 0.1852, "messageBoardId": "finmb_306632341", "gmtOffSetMilliseconds": -14400000, "marketState": "REGULAR", "market": "us_market", "exchange": "NCM", "shortName": "Akari Therapeutics Plc", "longName": "Akari Therapeutics, Plc", "firstTradeDateMilliseconds": 1389018600000, "priceHint": 4, "regularMarketChange": -0.0018999875, "regularMarketTime": 1684261008, "regularMarketDayHigh": 0.19, "regularMarketDayRange": "0.1845 - 0.19", "regularMarketDayLow": 0.1845, "regularMarketVolume": 57240, "regularMarketPreviousClose": 0.1871, "bid": 0.1851, "ask": 0.1915, "bidSize": 11, "askSize": 9, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 0.1871, "averageDailyVolume3Month": 491768, "averageDailyVolume10Day": 570080, "fiftyTwoWeekLowChange": 0.0432, "fiftyTwoWeekLowChangePercent": 0.30422536, "fiftyTwoWeekRange": "0.142 - 1.61", "fiftyTwoWeekHighChange": -1.4248, "fiftyTwoWeekHighChangePercent": -0.88496894, "fiftyTwoWeekLow": 0.142, "fiftyTwoWeekHigh": 1.61, "earningsTimestamp": 1682942401, "earningsTimestampStart": 1684234740, "earningsTimestampEnd": 1684497600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.3, "epsForward": -0.17, "epsCurrentYear": -0.2, "priceEpsCurrentYear": -0.926, "sharesOutstanding": 101116000, "bookValue": 0.024, "fiftyDayAverage": 0.21468, "fiftyDayAverageChange": -0.029479995, "fiftyDayAverageChangePercent": -0.13732064, "twoHundredDayAverage": 0.55505, "twoHundredDayAverageChange": -0.36985, "twoHundredDayAverageChangePercent": -0.66633636, "marketCap": 18726684, "forwardPE": -1.0894117, "priceToBook": 7.7166667, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "displayName": "Akari Therapeutics", "symbol": "AKTX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "75/76 Wimpole Street", "city": "London", "zip": "W1G 9RT", "country": "United Kingdom", "phone": "44 20 8004 0270", "website": "https://www.akaritx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barr\u00e9 syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.", "companyOfficers": [{"maxAge": 1, "name": "Ms. Rachelle Suzanne Jacques", "age": 51, "title": "Pres, CEO & Director", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 1383198, "fmt": "1.38M", "longFmt": "1,383,198"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 13590961, "fmt": "13.59M", "longFmt": "13,590,961"}}, {"maxAge": 1, "name": "Dr. Torsten  Hombeck Ph.D.", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 416297, "fmt": "416.3k", "longFmt": "416,297"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 2638000, "fmt": "2.64M", "longFmt": "2,638,000"}}, {"maxAge": 1, "name": "Ms. Melissa  Bradford-Klug", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Miles  Nunn", "age": 53, "title": "Chief Scientific Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. John F. Neylan III, M.D.", "age": 69, "title": "Exec. VP & Chief Medical Officer", "yearBorn": 1953, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Annie  Mack", "title": "Financial Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}